Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
IPO Year:
Exchange: NASDAQ
Website: https://www.nutexhealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/18/2024 | $45.00 | Buy | Maxim Group |
| 2/22/2023 | $3.00 | Outperform | Northland Capital |
Maxim Group initiated coverage of Nutex Health with a rating of Buy and set a new price target of $45.00
Northland Capital initiated coverage of Nutex Health with a rating of Outperform and set a new price target of $3.00
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4/A - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
HOUSTON, Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06
Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho, Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho. The staff of medical experts at Post Falls ER & Hospital are bringing the communities in Post Falls and Coeur d'Alene, Idaho and Spokane, Washington 24/7/365 days of concie
TOTAL REVENUE OF $143.5 MILLION FOR THE FIRST HALF 2024 VS $115.3 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 25%HOSPITAL DIVISION VISITS OF 81,276 FOR THE FIRST HALF 2024 VS VISITS OF 65,244 FOR THE FIRST HALF 2023, AN INCREASE OF 25%HOSPITAL DIVISION OPERATING INCOME OF $33.3 MILLION FOR THE FIRST HALF 2024 VS $13.9 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 140%NET CASH FROM OPERATING ACTIVITIES OF $16.3 MILLION FOR THE FIRST HALF 2024COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOWHOUSTON, Aug. 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro
HOUSTON, Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET. Participant Dial-In Numbers: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06250d
HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, announced today that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market as required by the Hearing Panel's June 14, 2024 decision, as previously disclosed in the Company's Current Report on F
HOUSTON, July 15, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced Nutex Health hospitals won nine awards in 2024's second quarter, reflecting the staff's commitment to excellence. Nutex Health hospitals have historically served as the safety net for the communities in which we serve. We believe that the main reason our hospitals are recognized for superior healthcare delivery is our organization's primary focus on patient care. Patients alway
HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024. The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306. The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for the continued listing on The Nasdaq Capital Market. The rev
COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 HOUSTON, June 19, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16. On June 14, 2024, the Company received notice from the Nasdaq Stock Market LLC ("Nasdaq") that a Nasdaq Hearings Panel had grant
HOUSTON, May 24, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter on May21, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), the Company's Common Stock would b
TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20%HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1%HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION IN 2023, AN INCREASE OF 119%NET CASH FROM OPERATING ACTIVITIES OF $3.1 MILLION FOR FIRST QUARTER 2024CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATIONHOUSTON, May 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21
SC 13G/A - Nutex Health, Inc. (0001479681) (Subject)
SC 13G - Nutex Health, Inc. (0001479681) (Subject)
SC 13D - Nutex Health, Inc. (0001479681) (Subject)
SC 13D - Nutex Health, Inc. (0001479681) (Subject)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
4 - Nutex Health, Inc. (0001479681) (Issuer)
8-K - Nutex Health, Inc. (0001479681) (Filer)
10-Q - Nutex Health, Inc. (0001479681) (Filer)
8-K - Nutex Health, Inc. (0001479681) (Filer)
8-K - Nutex Health, Inc. (0001479681) (Filer)
S-8 - Nutex Health, Inc. (0001479681) (Filer)
8-K - Nutex Health, Inc. (0001479681) (Filer)
8-K - Nutex Health, Inc. (0001479681) (Filer)
DEFA14A - Nutex Health, Inc. (0001479681) (Filer)
DEFA14A - Nutex Health, Inc. (0001479681) (Filer)
DEF 14A - Nutex Health, Inc. (0001479681) (Filer)
HOUSTON, April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors. They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment. The Board has determined that Mr. Saunders satisfies the current independent director standards established by the rules of The Nasdaq Stock Market. Mr. Saunders will s
HOUSTON, Sept. 5, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Joshua DeTillio as the Company's Chief Operating Officer effective on or about October 2, 2023. Mr. DeTillio is an experienced healthcare leader with over 20 years of hospital experience and 12 years as a CEO in investor-owned, publicly traded companies. He has demonstrated success in collaborating with and leading boards and physicians to drive growth, improve c
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
HOUSTON, Nov. 1, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06
HOUSTON, Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET. Participant Dial-In Numbers: 1-877-407-9208 or 1-201-493-6784 Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06250d
HOUSTON, May 7, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conference call on Friday, May 10, 2024 at 10:30am ET. Participant Dial-In Numbers: 1-877-407-9208 or 1-201-493-6784. To access the call, please dial in approximately five minutes before start ti
ACQUISITION EXPANDS COMPANY'S PRESENCE IN FLORIDA AND ADDS APPROXIMATELY 112 PRIMARY CARE PHYSICIANS AND 4400 MANAGED CARE PATIENTS TO THE NUTEX PLATFORM HOUSTON, Aug. 22, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that it has acquired Population Health Associates, Inc. ("PHA") and Managed Care Insurance Consultants, Inc. ("MCIC"). Founded in 1996 and based in Coral Gables, Florida, PHA and MCIC are independent practice associations ("IPAs")
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024. The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306. The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for the continued listing on The Nasdaq Capital Market.
Nutex Health a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16.
- SEC Filing
Gainers Holdco Nuvo Group DG (NASDAQ:NUVO) shares increased by 21.5% to $1.92 during Wednesday's after-market session. The company's market cap stands at $63.8 million. Entero Therapeutics (NASDAQ:ENTO) shares moved upwards by 8.69% to $2.25. The company's market cap stands at $6.1 million. OneMedNet (NASDAQ:ONMD) shares moved upwards by 7.4% to $1.45. The market value of their outstanding shares is at $34.5 million. China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock increased by 5.92% to $0.29. Nutex Health (NASDAQ:NUTX) stock increased by 5.53% to $0.57. The market value of their outstanding shares is at $28.3 million. Inspire Veterinary (NASDAQ:IVP) stock increased by 5.05%
Shares of Calavo Growers, Inc. (NASDAQ:CVGW) rose sharply in today's pre-market trading after the company reported second-quarter financial results. Total net sales surged 16.5% year-over-year to $184.4 million during the quarter. Adjusted net income surged to $8.9 million, or 50 cents per diluted share, from $5.1 million, or 29 cents per diluted share for the year-ago quarter. Calavo Growers shares jumped 11.6% to $27.90 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers ShiftPixy, Inc. (NASDAQ:PIXY) rose 41.1% to $2.06 in today's pre-market trading. Nauticus Robotics, Inc. (NASDAQ:KITT) shares rose 27.2% to $0.2938 in pre-
Nutex Health (NASDAQ:NUTX) reported quarterly losses of $(0.01) per share. This is a 93.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $67.45 million which beat the analyst consensus estimate of $64.80 million by 4.10 percent. This is a 19.75 percent increase over sales of $56.33 million the same period last year.
Nutex Health fully intends to consider all available options to resolve the deficiency in the NASDAQ minimum bid price with every intention to regain compliance with NASDAQ listing requirements. Nutex Health has placed a moratorium on the opening of any further new hospitals in 2024 until certain financial metrics have been achieved. Management is advancing its previously announced strategic plan designed to significantly reduce costs, reach positive net income and improve cash flow. The Company continues to monitor underperforming facilities and may decide to close or sell more underperforming facilities in the near future. The Company believes that it has a strong balance sheet, expect
Shares of Ascent Solar Technologies, Inc. (NASDAQ:ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Ascent Solar Technologies shares dipped 50% to $0.1374 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Marin Software Incorporated (NASDAQ:MRIN) shares jumped 152% to $0.7242 after the company announced upgrades to its integration with Microsoft Advertising. Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) gained 75% to $1.9698 after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high